🟢 Rezolute is trading 5.6% up in after-hours trading despite no identified catalyst

Rezolute is trading at $4.88, up 5.63% after an unexplained after-hours rebound following its August 28 regular-session decline.

• Shares fell 7.23% during the August 28 regular session amid a broader biotech-sector selloff.
• Searches found no new August 28 earnings release, clinical update, FDA action, financing, or analyst catalyst; the latest identified investor-relations announcement was dated July 21.
• Investors may be positioning ahead of Rezolute’s anticipated second-half 2026 upLIFT data update.